These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 39080215

  • 1. COLEC10 inhibits the stemness of hepatocellular carcinoma by suppressing the activity of β-catenin signaling.
    Cai MN, Chen DM, Chen XR, Gu YR, Liao CH, Xiao LX, Wang JL, Lin BL, Huang YH, Lian YF.
    Cell Oncol (Dordr); 2024 Oct; 47(5):1897-1910. PubMed ID: 39080215
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. WM130 preferentially inhibits hepatic cancer stem-like cells by suppressing AKT/GSK3β/β-catenin signaling pathway.
    Ni CX, Qi Y, Zhang J, Liu Y, Xu WH, Xu J, Hu HG, Wu QY, Wang Y, Zhang JP.
    Oncotarget; 2016 Nov 29; 7(48):79544-79556. PubMed ID: 27783993
    [Abstract] [Full Text] [Related]

  • 5. Regulatory T cells inhibit FoxP3 to increase the population of tumor initiating cells in hepatocellular carcinoma.
    Liu C, Tu YJ, Cai HY, Pan YY, Wu YY, Zhang L.
    J Cancer Res Clin Oncol; 2024 Jul 29; 150(7):373. PubMed ID: 39073490
    [Abstract] [Full Text] [Related]

  • 6. PAF enhances cancer stem cell properties via β-catenin signaling in hepatocellular carcinoma.
    Li M, Mu XD, Song JR, Zhai PT, Cheng Y, Le Y, Li ZB.
    Cell Cycle; 2021 May 29; 20(10):1010-1020. PubMed ID: 33970778
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Jiedu Recipe, a compound Chinese herbal medicine, inhibits cancer stemness in hepatocellular carcinoma via Wnt/β-catenin pathway under hypoxia.
    Guo BJ, Ruan Y, Wang YJ, Xiao CL, Zhong ZP, Cheng BB, Du J, Li B, Gu W, Yin ZF.
    J Integr Med; 2023 Sep 29; 21(5):474-486. PubMed ID: 37453868
    [Abstract] [Full Text] [Related]

  • 9. Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway.
    Zheng Y, Jiang L, Hu Y, Xiao C, Xu N, Zhou J, Zhou X.
    BMC Cancer; 2017 Feb 28; 17(1):161. PubMed ID: 28241806
    [Abstract] [Full Text] [Related]

  • 10. Downregulation of Cancer Stemness by Novel Diterpenoid Ovatodiolide Inhibits Hepatic Cancer Stem Cell-Like Traits by Repressing Wnt/[Formula: see text]-Catenin Signaling.
    Liu M, Bamodu OA, Kuo KT, Lee WH, Lin YK, Wu ATH, M H, Tzeng YM, Yeh CT, Tsai JT.
    Am J Chin Med; 2018 Feb 28; 46(4):891-910. PubMed ID: 29792038
    [Abstract] [Full Text] [Related]

  • 11. Cripto-1 contributes to stemness in hepatocellular carcinoma by stabilizing Dishevelled-3 and activating Wnt/β-catenin pathway.
    Lo RC, Leung CO, Chan KK, Ho DW, Wong CM, Lee TK, Ng IO.
    Cell Death Differ; 2018 Aug 28; 25(8):1426-1441. PubMed ID: 29445127
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma.
    Toh TB, Lim JJ, Hooi L, Rashid MBMA, Chow EK.
    J Hepatol; 2020 Jan 28; 72(1):104-118. PubMed ID: 31541681
    [Abstract] [Full Text] [Related]

  • 14. Enrichment of cancer stem cells via β-catenin contributing to the tumorigenesis of hepatocellular carcinoma.
    Pandit H, Li Y, Li X, Zhang W, Li S, Martin RCG.
    BMC Cancer; 2018 Aug 03; 18(1):783. PubMed ID: 30075764
    [Abstract] [Full Text] [Related]

  • 15. EPHB2 Activates β-Catenin to Enhance Cancer Stem Cell Properties and Drive Sorafenib Resistance in Hepatocellular Carcinoma.
    Leung HW, Leung CON, Lau EY, Chung KPS, Mok EH, Lei MML, Leung RWH, Tong M, Keng VW, Ma C, Zhao Q, Ng IOL, Ma S, Lee TK.
    Cancer Res; 2021 Jun 15; 81(12):3229-3240. PubMed ID: 33903122
    [Abstract] [Full Text] [Related]

  • 16. Y-box binding protein-1 promotes hepatocellular carcinoma-initiating cell progression and tumorigenesis via Wnt/β-catenin pathway.
    Chao HM, Huang HX, Chang PH, Tseng KC, Miyajima A, Chern E.
    Oncotarget; 2017 Jan 10; 8(2):2604-2616. PubMed ID: 27911878
    [Abstract] [Full Text] [Related]

  • 17. Targeting the Epigenetic Non-Coding RNA MALAT1/Wnt Signaling Axis as a Therapeutic Approach to Suppress Stemness and Metastasis in Hepatocellular Carcinoma.
    Chang HL, Bamodu OA, Ong JR, Lee WH, Yeh CT, Tsai JT.
    Cells; 2020 Apr 20; 9(4):. PubMed ID: 32326045
    [Abstract] [Full Text] [Related]

  • 18. ATP-citrate lyase regulates stemness and metastasis in hepatocellular carcinoma via the Wnt/β-catenin signaling pathway.
    Han Q, Chen CA, Yang W, Liang D, Lv HW, Lv GS, Zong QN, Wang HY.
    Hepatobiliary Pancreat Dis Int; 2021 Jun 20; 20(3):251-261. PubMed ID: 33129711
    [Abstract] [Full Text] [Related]

  • 19. TNF-α derived from M2 tumor-associated macrophages promotes epithelial-mesenchymal transition and cancer stemness through the Wnt/β-catenin pathway in SMMC-7721 hepatocellular carcinoma cells.
    Chen Y, Wen H, Zhou C, Su Q, Lin Y, Xie Y, Huang Y, Qiu Q, Lin J, Huang X, Tan W, Min C, Wang C.
    Exp Cell Res; 2019 May 01; 378(1):41-50. PubMed ID: 30844387
    [Abstract] [Full Text] [Related]

  • 20. Silencing MYH9 blocks HBx-induced GSK3β ubiquitination and degradation to inhibit tumor stemness in hepatocellular carcinoma.
    Lin X, Li AM, Li YH, Luo RC, Zou YJ, Liu YY, Liu C, Xie YY, Zuo S, Liu Z, Liu Z, Fang WY.
    Signal Transduct Target Ther; 2020 Feb 14; 5(1):13. PubMed ID: 32296025
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.